Trevi Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TRVI and other ETFs, options, and stocks.

About TRVI

Trevi Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of Haduvio to treat serious neurologically mediated conditions. It includes treatment of chronic pruritus associated with prurigo nodularis and chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson’s disease. 

CEO
Jennifer L. Good
CEOJennifer L. Good
Employees
26
Employees26
Headquarters
New Haven, Connecticut
HeadquartersNew Haven, Connecticut
Founded
2011
Founded2011
Employees
26
Employees26

TRVI Key Statistics

Market cap
625.53M
Market cap625.53M
Price-Earnings ratio
-13.76
Price-Earnings ratio-13.76
Dividend yield
—
Dividend yield—
Average volume
1.22M
Average volume1.22M
High today
$6.49
High today$6.49
Low today
$6.01
Low today$6.01
Open price
$6.31
Open price$6.31
Volume
1.15M
Volume1.15M
52 Week high
$7.39
52 Week high$7.39
52 Week low
$2.30
52 Week low$2.30

Analyst ratings

100%

of 10 ratings
Buy
100%
Hold
0%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.